🔎 Trials Near Me

መነሻ › Multiple Myeloma › ካሊፎርኒያ › Los Angeles

በLos Angeles፣ CA ለMultiple Myeloma የሚደረጉ ክሊኒካዊ ጥናቶች

ለMultiple Myeloma የሚደረጉ 17 ጥናቶች በLos Angeles እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • USC Norris Comprehensive Cancer Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07258511

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Valkyrie Clinical Trials, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07518186

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • Berenson Cancer Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07609940

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Valkyrie Clinical Trials, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05552222

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT02693535

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Cedars-Sinai Medical Center /ID# 278238, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07095452

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UCLA Hematology/Oncology - Santa Monica, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UCLA Hematology/Oncology - Westwood (Building 200 Suite 214), Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06297226

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Southern California /ID# 272414, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06953960

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Clinical Research Advisors (Korea Town Satellite Location), Los Angeles
  • Clinical Research Advisors (West Hollywood Satellite Location), Los Angeles
  • Valkyrie Clinical Trials, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT06152575

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • GSK Investigational Site, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT05714839

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05850234

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Cedars-Sinai Medical Center, Los Angeles
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ10 ኦገስ 2026 · NCT05887167

Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma

ተሳታዮችን በመፈለግ ላይ
  • Los Angeles General Medical Center, Los Angeles
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ጁን 2026 · NCT03858205

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UCLA Medical Center, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ጁን 2026 · NCT05243797

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of California Los Angeles (UCLA), Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2026 · NCT05828511

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Valkyrie Clinical Trials, Los Angeles
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2025 · NCT06119685

በሌሎች ከተሞች ለMultiple Myeloma የሚደረጉ ጥናቶች

በLos Angeles ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።